ProfileGDS5678 / 1427409_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 3% 12% 3% 3% 6% 3% 3% 3% 3% 3% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4380317
GSM967853U87-EV human glioblastoma xenograft - Control 21.982893
GSM967854U87-EV human glioblastoma xenograft - Control 32.2898612
GSM967855U87-EV human glioblastoma xenograft - Control 41.91453
GSM967856U87-EV human glioblastoma xenograft - Control 51.921153
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.14376
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.000843
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.968933
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.96433
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.966963
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.974143
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.927753
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.975013
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.981223